These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12920022)

  • 21. Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
    Papadakis KA; Krempski J; Reiter J; Svingen P; Xiong Y; Sarmento OF; Huseby A; Johnson AJ; Lomberk GA; Urrutia RA; Faubion WA
    Am J Physiol Cell Physiol; 2015 Mar; 308(5):C362-71. PubMed ID: 25472963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.
    Li MO; Sanjabi S; Flavell RA
    Immunity; 2006 Sep; 25(3):455-71. PubMed ID: 16973386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
    Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus.
    Song HM; Fong KD; Nacamuli RP; Warren SM; Fang TD; Mathy JA; Cowan CM; Aalami OO; Longaker MT
    Plast Reconstr Surg; 2004 May; 113(6):1685-97. PubMed ID: 15114130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in Mice.
    Hu JH; Wei H; Jaffe M; Airhart N; Du L; Angelov SN; Yan J; Allen JK; Kang I; Wight TN; Fox K; Smith A; Enstrom R; Dichek DA
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2647-56. PubMed ID: 26494233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelium-specific adenoviral transfer of a dominant-negative mutant TGF-beta type II receptor stimulates embryonic lung branching morphogenesis in culture and potentiates EGF and PDGF-AA.
    Zhao J; Sime PJ; Bringas P; Gauldie J; Warburton D
    Mech Dev; 1998 Mar; 72(1-2):89-100. PubMed ID: 9533955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.
    Mallat Z; Gojova A; Marchiol-Fournigault C; Esposito B; Kamaté C; Merval R; Fradelizi D; Tedgui A
    Circ Res; 2001 Nov; 89(10):930-4. PubMed ID: 11701621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.
    Gorelik L; Flavell RA
    Immunity; 2000 Feb; 12(2):171-81. PubMed ID: 10714683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling.
    Yoo BM; Yeo M; Oh TY; Choi JH; Kim WW; Kim JH; Cho SW; Kim SJ; Hahm KB
    Pancreas; 2005 Apr; 30(3):e71-9. PubMed ID: 15782092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.
    Gao Y; Qian WP; Dark K; Toraldo G; Lin AS; Guldberg RE; Flavell RA; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16618-23. PubMed ID: 15531637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer T cells accelerate atherogenesis in mice.
    Nakai Y; Iwabuchi K; Fujii S; Ishimori N; Dashtsoodol N; Watano K; Mishima T; Iwabuchi C; Tanaka S; Bezbradica JS; Nakayama T; Taniguchi M; Miyake S; Yamamura T; Kitabatake A; Joyce S; Van Kaer L; Onoé K
    Blood; 2004 Oct; 104(7):2051-9. PubMed ID: 15113755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discoidin Domain Receptor-1 Regulates Calcific Extracellular Vesicle Release in Vascular Smooth Muscle Cell Fibrocalcific Response via Transforming Growth Factor-β Signaling.
    Krohn JB; Hutcheson JD; Martínez-Martínez E; Irvin WS; Bouten CV; Bertazzo S; Bendeck MP; Aikawa E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):525-33. PubMed ID: 26800565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1995-2003. PubMed ID: 9351364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
    Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
    J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells.
    Sinha S; Hoofnagle MH; Kingston PA; McCanna ME; Owens GK
    Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1560-8. PubMed ID: 15306544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of TGF-beta signaling contributes to autoimmune pancreatitis.
    Hahm KB; Im YH; Lee C; Parks WT; Bang YJ; Green JE; Kim SJ
    J Clin Invest; 2000 Apr; 105(8):1057-65. PubMed ID: 10772650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AKT hyperactivation confers a Th1 phenotype in thymic Treg cells deficient in TGF-β receptor II signaling.
    Liu Y; Xu Y; Sun J; Ma A; Zhang F; Xia S; Xu G; Liu Y
    Eur J Immunol; 2014 Feb; 44(2):521-32. PubMed ID: 24165986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.